581-600 of 860 results with category "Critical Care"

Previous  |  1 |  ... |  25 |  26 |  27 |  28 |  29 |  30 |  31 |  32 |  33 |  34 |  35 |  ... |  43 |  Next

Title: Ultrasound-Guided Pericardiocentesis

Category: Critical Care

Posted: 12/11/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

Ultrasound-Guided Pericardiocentesis

Show References



Title: Labs in Anaphylaxis

Category: Critical Care

Keywords: anaphylaxis, tryptase, diagnosis (PubMed Search)

Posted: 12/6/2012 by Ellen Lemkin, MD, PharmD (Updated: 3/4/2026)

Show References



Title: Management of AKI

Category: Critical Care

Posted: 11/27/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

Managing Critically Ill Patients with AKI

Show References



Title: How Low, Should You Go?

Category: Critical Care

Posted: 11/20/2012 by Haney Mallemat, MD

A low-tidal volume (or protective) strategy of mechanical ventilation (i.e., tidal volume of 6-8cc/kg of ideal body weight) has previously been demonstrated to be beneficial in patients with acute respiratory distress syndrome (ARDS).

A meta-analysis was recently performed to determine whether this strategy of mechanical ventilation is also beneficial for patients without lung injury prior to initiation of mechanical ventilation.

Dr. Neto, et al. performed a meta-analysis of 20 studies (total of 2,822 mechanically ventilated patients) comparing a conventional ventilation strategy (average tidal volume was 10.6 cc/kg) to a protective ventilation strategy (average tidal volume was 6.4 cc/kg) of mechanical ventilation.

The authors concluded that patients ventilated with a protective lung-strategy had reductions in:

Bottom-line: This meta-analysis supports the notion that a strategy of low-tidal volume ventilation may have benefits for patients without ARDS, however prospective studies are needed.

Show References



Title: Antibiotic Dosing for Burn Patients

Category: Critical Care

Posted: 11/13/2012 by Mike Winters, MBA, MD

Burn Patients and Antibiotic Dosing

Show References



Title: Too much salt may NOT be sweet.

Category: Critical Care

Posted: 11/6/2012 by Haney Mallemat, MD

Previous pearls have described the increasing evidence against colloid (e.g., hydroxyethyl starch) use during resuscitation. Now it appears that the crystalloid 0.9% normal saline (NS) may be under fire. 

The use of large volumes of NS has been associated with hyperchloremic metabolic acidosis and harm in animal studies. The risk of harm in humans, however, has been less clear. 

Bellomo et al. conducted a prospective observational study in which patients being resuscitated in the control group received NS at the clinicians' discretion; i.e., chloride-liberal strategy. The use of NS was restricted in the intervention group, where other less chloride containing fluids were used for resuscitation (e.g., Ringer's Lactate); i.e., a chloride-restrictive strategy. 

The authors found that when compared to patients in the chloride-liberal group, the chloride-restrictive group had significantly less rise in baseline creatinine, less overall AKI, and a reduced need for renal replacement therapy.

Bottom line: Although this was only an observational study, the liberal use of normal saline during resuscitation may increase the risk of AKI and renal replacement therapy. 

Show References



Title: Serotonin Toxicity

Category: Critical Care

Posted: 10/30/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

Serotonin Toxicity in the Critically Ill

Show References



Title: Sugar isn't always so sweet

Category: Critical Care

Posted: 10/24/2012 by Haney Mallemat, MD (Updated: 10/24/2012)

A study by Perner, et al recently published in NEJM observed that using hydroxyethyl starch (HES) as a resuscitation fluid increased mortality and renal replacement therapy at 90 days as compared to lactated acetate.
 
Another recent trial, called the “Crystalloid versus Hydroxyethyl Starch Trial” (CHEST) was a prospective randomized control trial from Australia comparing the use of 6% HES and 0.9% sodium chloride as a resuscitation fluid in the critically ill. 
 
With 7,000 patients enrolled (3,500 in each group), the CHEST trial is the largest single-trial of HES to date; the primary outcome was 90-day mortality and secondary outcomes were acute kidney injury (AKI) and renal-replacement therapy
 
The study concluded that there was no difference between groups for either morality or renal failure, but significantly more patients in the HES group required renal replacement therapy.
 
Bottom line: There is still no convincing data that patients receiving HES as part of their resuscitation have better outcomes compared to crystalloid (normal saline or lactated ringers) and there is increased harm with their use. Furthermore, the increased cost of HES does not appear to justify their routine use.

Show References



Title: Delirium in the Critically Ill

Category: Critical Care

Posted: 10/16/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

Delirium in the Critically Ill

Show References



Title: What's the Diagnosis? Critical Care Edition

Category: Critical Care

Posted: 10/9/2012 by Haney Mallemat, MD

Question

70 year-old male recently treated for community-acquired pneumonia presents with bloody diarrhea, fever, and severe abdominal pain. Abdominal Xray is shown below. Diagnosis?  

Show Answer

Show References



Title: TTP

Category: Critical Care

Posted: 10/2/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

Thrombotic Thrombocytopenic Purpura (TTP)

Show References



Title: Does a cuff-leak mean anything?

Category: Critical Care

Posted: 9/25/2012 by Haney Mallemat, MD

Intubated patients may occasionally meet certain criteria for extubation while in the Emergency Department. Extubation is not without its risk, however, as up to 30% of patients have respiratory distress secondary to laryngeal and upper airway edema, with some patients requiring re-intubation.

Prior to extubation, Intensivists use a brief “cuff-leak” test (deflation of the endotracheal balloon to assess the presence or absence of an air-leak around the tube) to indirectly screen for the presence of upper airway edema and ultimately the risk of re-intubation. The cuff-leak test is performed by deflating the endotracheal balloon followed by one or more of the following maneuvers:

Ochoa et al. performed a systematic review to determine the accuracy of the “cuff-leak” test to predict upper airway edema prior to extubation. The authors concluded that a positive cuff-leak test (i.e., absence of an air-leak) indicates an elevated risk of upper airway obstruction and re-intubation. A negative cuff-leak test (i.e., presence of an air-leak), however, does not reliably exclude the presence of upper airway edema or the need for subsequent re-intubation.

Bottom line: No test prior to extubation reliably predicts the absence of upper airway edema. Patients extubated in the Emergency Department require close observation with airway equipment located nearby.

 

Show References



Title: Lung Transplant Pt.

Category: Critical Care

Posted: 9/18/2012 by Mike Winters, MBA, MD

The Lung Transplant Patient in Your ED

Show References



Title: Non-Cardiogenic Pulmonary Edema

Category: Critical Care

Posted: 9/11/2012 by Haney Mallemat, MD

Question

40 year-old male with severe uncontrolled hypertension presents with altered mental status (head CT below). The CXR is from the same patient. What's the connection?

Show Answer

Show References



Title: Right Heart Failure in the Critically Ill

Category: Critical Care

Posted: 9/4/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

Right Heart Failure in the Critically Ill

Show References



Title: What's the paralytic of choice during rapid sequence intubation?

Category: Critical Care

Posted: 8/28/2012 by Haney Mallemat, MD

A Cochrane review of 37 studies concluded that Succinylcholine (SUC) is superior to Rocuronium (ROC) during rapid sequence intubation.

The authors claim that compared to ROC, SUC has a faster onset of action (45 vs. 60 seconds) and overall a shorter duration of action (10 vs. 60 minutes).

Dr. Reuben Strayer wrote a letter to the journal editors and stated that these findings should be interpreted carefully; he highlighted that most of the studies in the review used doses of ROC less than 0.9 mg/kg (most studies used 0.6mg/kg).

Dr. Strayer asserted that ROC’s onset of action is dose dependent; when using doses of 1.2 mg/kg, ROC’s onset is indistinguishable from that of SUC. He also stated another major benefit of ROC is the lack of adverse effects that SUC possesses (hyperkalemia and malignant hyperthermia).

What are your thoughts on this? Go to http://www.facebook.com/Criticalcarenow and take the poll (there are 5 choices). Results will be posted next week.

Show References



Title: Fluids and AKI

Category: Critical Care

Posted: 8/21/2012 by Mike Winters, MBA, MD (Updated: 3/4/2026)

AKI and Fluid Balance

Show References



Title: Are femoral-lines really that bad?

Category: Critical Care

Posted: 8/14/2012 by Haney Mallemat, MD

Femoral venous access is typically limited to the acute resuscitation of critically-ill patients. Several practice-guidelines recommend avoiding the femoral site, or removal once admitted to the ICU, because of the risk of catheter-related bloodstream infection (CRBI) and deep-vein thrombosis (DVT).

A recent systematic review and meta-analysis (including two randomized-control trials and eight cohort-studies) evaluated the risk of CRBI and DVT for catheters placed in either the internal jugular, subclavian, or femoral-venous sites. No difference in the rate of CRBI or DVT was found between the three sites, although the DVT data was less robust (i.e., contained heterogeneous data).

The authors hypothesized that improvements in sterility during central-line placement (e.g., full-barrier precautions), improved nursing care (e.g., central-line site care), and ultrasound guidance may have led to a reduction in femoral site complications. 

Although a prospective randomized-control trial is necessary to confirm these results, this meta-analysis challenges the traditional teaching that femoral central-access should be avoided.

Show References



Title: Low-Tidal Volume Ventilation Still Underutilized

Category: Critical Care

Posted: 8/7/2012 by Mike Winters, MBA, MD

Lung Protective Ventilator Settings Still Underutilized

Show References



Title: Crystalloids: A Brief History

Category: Critical Care

Posted: 7/31/2012 by Haney Mallemat, MD

Crystalloids (i.e., 0.9% saline and lactated ringers) have been used during resuscitation for more than a century. Their invention, however, was more accidental than intentional.

Crystalloids were first used during the European Cholera epidemic of 1831. Hartog Hamburger later modified this solution in 1896 to the solution we know today as "normal" saline. Hamburger's solution was only intended for in vitro study of RBC lysis and was never intended for clinical use.  

Around this time, Sydney Ringer was testing several fluids to use for physiologic studies. Ringer's lab assistant was erroneously substituting tap water for distilled water when preparing these solutions. Ringer later discovered that this tap water contained minerals making the solution "physiologic", isotonic, and safe for human use; Alexis Hartmann later added sodium lactate to create Ringer's Lactate. 

Since the invention of crystalloids, many types of resuscitation fluids have been created and studied (i.e., albumins, gelatins, and starches); all have been shown to be more expensive, with no more benefit, and with possibly more harm when compared to crystalloids. 

The "perfect" resuscitation fluid still alludes us today, but of all of the solutions marketed crystalloids are arguably the best...despite their accidental history.

Show References



Previous  |  1 |  ... |  25 |  26 |  27 |  28 |  29 |  30 |  31 |  32 |  33 |  34 |  35 |  ... |  43 |  Next